Showing results (1181-1190 of 2,811) with videos related to
Sort By:
Pageof 282
Expert Opinion on Drug Safety|April 15, 2016
Adverse neuropsychiatric effects of antimalarial drugsBryan Grabias, Sanjai KumarExpert Opinion on Drug Safety|April 16, 2016
Are all heparins safe for on-pump heart surgery?Kasra Azarnoush, Bruno Pereira, Aurelien Lebreton, et al.Expert Opinion on Drug Safety|August 22, 2017
Clinical applications and safety evaluation of the new CD19 specific T-cell engager antibody construct blinatumomabAnne C Wilke, Nicola GökbugetExpert Opinion on Drug Safety|August 23, 2017
Safety evaluation of trelagliptin in the treatment of Japanese type 2 diabetes mellitus patientsKohei KakuExpert Opinion on Drug Safety|July 26, 2017
Sodium glucose co-transporter 2 inhibitor luseogliflozin in the management of type 2 diabetes: a drug safety evaluationDaisuke Yabe, Yoshiyuki Hamamoto, Yusuke Seino, et al.Expert Opinion on Drug Safety|July 22, 2017
The safety of available and emerging options for emergency contraceptionJessica K Lee, Eleanor Bimla SchwarzExpert Opinion on Drug Safety|August 3, 2017
Risk of gastrointestinal complications in breast cancer patients treated with neratinib: a meta-analysisNan Jiang, Xiang-Wei Song, Jing-Jing Lin, et al.Expert Opinion on Drug Safety|October 24, 2017
Statin drug interactions and related adverse reactions: an updateStefano Bellosta, Alberto CorsiniExpert Opinion on Drug Safety|October 21, 2017
The safety and efficacy of dabrafenib and trametinib for the treatment of melanomaSarah Knispel, Lisa Zimmer, Theodora Kanaki, et al.Expert Opinion on Drug Safety|September 19, 2017
Recommendations on managing lenvatinib and everolimus in patients with advanced or metastatic renal cell carcinomaE Grande, H Glen, J Aller, et al.Pageof 282